FDA Approval Activities for this Drug
Cosopt (Dorzolamide/Timolol Solution), Merck NDA 20-869/S12 4/23/02 5/2/02 4/26/02
Cosopt/dorzolamide HCl and timolol maleate ophthalmic solution Merck NDA 20-869/S1 1/4/99 7/3/01
Cosopt/dorzolamide HCl and timolol maleate ophthalmic solution Merck NDA 20-869 Trusopt (dorzolamide hydrochloride ophthalmic solution), 2% Merck & Co., NDA 20-408/S-025 4/9/02 4/16/02 4/9/02
Trusopt (dorzolamide hydrochloride ophthalmic solution), 2 % Merck & Co., NDA 20-408/S-023 | Cosopt (dorzolamide hydrochloride-timolol maleate) ophthalmic solution, Merck & Co., Labeling Revision | COSOPT (dorzolamide hydrochloride-timolol maleate ophthalmic solution), Merck & Co., Labeling Revision | COSOPT (dorzolomide hydrochloride-timolol maleate), Merck & Co., Labeling Revision | COSOPT (dorzolamide hydrochloride-timolol maleate ophthalmic solution), Merck, Labeling Revision | Cosopt (dorzolamide hydrochloride and timolol maleate) Ophthalmic Solution, Merck & Co., Inc., Labeling Revision | Trusopt (dorzolamide hydrochloride) Ophthalmic Solution, Merck & Co., Inc., Labeling Revision | Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, Apotex Corp., Approval | Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, Hi-Tech Pharmacal Co., Inc., Approval | Dorzolamide Hydrochloride Ophthalmic Solution, Sandoz Canada Inc., Approval | Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, Sandoz Canada Inc., Approval